NF-κB Signaling
Nuclear factor κB (NF-κB) signaling regulates transcription through a family of interacting dimers and inhibitory proteins. Canonical and non-canonical frameworks help organize the system, but they are not completely isolated routes. Their inputs, regulatory complexes and dynamics matter more than a simple label such as an inflammatory or cancer “switch.” [1], [2]
Explore molecular tools
On this page
Canonical signaling: releasing regulated dimersNon-canonical signaling: NIK and p100 processingFeedback, timing and signaling historyTranscriptional outputs in contextReading the pathway and choosing a routeMolecular tool routesRelated readingReferencesCanonical signaling: releasing regulated dimers
Canonical NF-κB signaling commonly involves the IκB kinase (IKK) complex, including IKKβ and the regulatory component NEMO. Phosphorylation of inhibitory IκB proteins can promote their ubiquitination and degradation, allowing associated NF-κB dimers to redistribute and regulate transcription. The sequence connects upstream signaling machinery with a change in transcription-factor availability. [1], [2]
The role of ubiquitin is broader than protein destruction. Ubiquitin-dependent scaffolds can organize upstream signaling complexes, including interactions involving NEMO, while ubiquitination of IκB participates in its degradation. These are different functions of a common modification system and should not be merged into one generic degradation step. [1], [3]
Non-canonical signaling: NIK and p100 processing
The non-canonical framework centers on NF-κB-inducing kinase (NIK), IKKα and regulated processing of p100 to p52. Selected tumor necrosis factor receptor family inputs can stabilize NIK by changing the machinery that normally keeps its abundance low. The resulting pathway can support p52/RelB-associated transcriptional responses. It is not a universal response to every receptor that activates NF-κB. [2]
p100 is both a precursor and a regulatory protein, which links its processing to the wider availability of NF-κB dimers. Canonical and non-canonical components can consequently influence one another. RelB detection is not an exclusive marker of one completely separate route, and IKKα has functions beyond a single non-canonical signaling step. [1], [2]
Feedback, timing and signaling history
New synthesis of IκBα provides feedback that can restrain NF-κB activity after an initial response. Other regulators, including A20 and p100-associated mechanisms, influence how the system responds over time and to repeated input. Pulses or oscillations can arise in particular settings, but their presence and timing are not universal properties of every cell or stimulus. [1]
Non-canonical responses often develop more slowly and persist differently from rapid canonical activation, reflecting regulation that includes changes in protein abundance and processing. This distinction is useful as a framework, not a fixed timetable. Feedback, receptor context and communication between the branches can change the observed dynamics. [2]
Transcriptional outputs in context
NF-κB-associated genes participate in immune responses, survival and other cellular programs. The output depends on which dimers are available, their regulatory environment and the state of the cell. Calling the system uniformly pro-inflammatory or pro-cancer loses this context and can obscure different responses within the same tissue. [1], [2]
Nuclear localization, DNA-associated activity and changes in gene expression are connected observations, but they are not equivalent. An altered cellular phenotype lies farther downstream and integrates additional pathways. Likewise, a response to an inhibitor does not by itself identify the initiating receptor or establish direct engagement of an IKK or NF-κB protein. [1]
Reading the pathway and choosing a route
A canonical-pathway question can focus on IκB regulation and the release of dimers; a non-canonical question can focus on NIK stability and p100 processing. A dynamics question instead concerns feedback and the sequence of responses. Keeping these questions separate makes it easier to distinguish a change in pathway organization from a change in the amount of one measured protein. [1], [2]
The NF-κB and NF-κB/IκB catalog routes provide relevant molecular entry points. Innate Immunity & Pattern Recognition and Inflammation & Immune-Mediated Disease provide complementary biological contexts; this guide concentrates on the molecular transmission and regulation of the NF-κB response.
Molecular tool routes
| Molecular route | Research focus |
|---|---|
| NF-κB | NF-κB-associated tools. |
| NF-κB / IκB | Broader pathway category; not a dedicated IKK collection. |
References
- Mitchell S, Vargas J, Hoffmann A. Signaling via the NFκB system. Wiley interdisciplinary reviews. Systems biology and medicine. 2016. DOI: 10.1002/wsbm.1331. PMID: 26990581. PubMed · PMC
- Sun SC. The non-canonical NF-κB pathway in immunity and inflammation. Nature reviews. Immunology. 2017. DOI: 10.1038/nri.2017.52. PMID: 28580957. PubMed · PMC
- Swatek KN, Komander D. Ubiquitin modifications. Cell research. 2016. DOI: 10.1038/cr.2016.39. PMID: 27012465. PubMed · PMC